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Abstract
Background—Whether higher penile human papillomavirus(HPV) viral load is associated with 
a lower rate of HPV clearance remains unknown.
Objectives—We examined the association between penile HPV16 and HPV18 viral load and 
subsequent HPV clearance in uncircumcised Kenyan men.
Study Design—Participants were HIV-seronegative, sexually active, 18–24 year old men 
randomized to the control arm of a male circumcision trial in Kisumu, Kenya. Men provided 
exfoliated penile cells from two anatomical sites (glans/coronal sulcus and shaft) every 6 months 
for 2 years. GP5+/6+ polymerase chain reaction(PCR) was used to identify 44 HPV-DNA types. 
HPV viral load testing was conducted using a LightCyler real-time PCR assay; viral load was 
classified as high(> 250 copies/scrape) or low(≤250 copies/scrape), for non-quantifiable values. 
The Kaplan-Meier method and Cox regression modelling were used to examine the association 
between HPV viral load and HPV clearance.
Corresponding Author: Virginia Senkomago, PhD, MPH, Department of Epidemiology, University of North Carolina, Chapel Hill, 
North Carolina, 27514, epi.senkvirg@unc.edu. 
Conflicts of Interests: V. Senkomago has analyzed data for other projects in collaboration with Trovagene Inc. and Gen-Probe. DM. 
Backes, MG. Hudgens, C. Poole, SR. Meshnick, N. Schlecht, S. Moses, K. Agot, AT. Hesselink, and R.C. Bailey do not have a 
conflict of interest with this manuscript. J. S. Smith has received consultancy and/or research grants from GSK and Merck Corporation 
over the past five years. P. Snijders has received speaker fees from Roche, Qiagen, Gen-Probe, Abbott Seegene, and has minority stake 
in Self-screen, and CJL Meijer has received speaker fees from GSK, Roche, Qiagen, SPSMD/Merck, Seegene, and has minority stake 
in Diassay and Self-screen.
Ethics Approval
The study protocol was approved by Institutional Review Boards of the Universities of Illinois at Chicago, Manitoba, Nairobi and 
North Carolina; RTI International and VU University Medical Center. The trial is registered at clinicaltrials.gov, NCT00059371.
HHS Public Access
Author manuscript
Sex Transm Dis. Author manuscript; available in PMC 2017 September 01.
Published in final edited form as:













brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by Carolina Digital Repository
Results—A total of 1097 men, with 291 HPV16 and 131 HPV18 cumulative infections over 24 
months were analyzed. HPV clearance at 6 months after first HPV detection was lower for high 
versus low viral load HPV16 infections in the glans [adjusted hazard ratio (aHR) = 0.65(95% 
confidence interval, 0.46-0.92)] and shaft (aHR=0.44(0.16-0.90), and HPV18 infections in the 
glans [aHR=0.05(0.01-0.17)].
Discussion—High versus low HPV viral load was associated with reduced HPV clearance for 
HPV16 infections in the glans and shaft, and for HPV18 infections in the glans, among young 
uncircumcised men. Reduced clearance of high viral load HPV16 and HPV18 infections in men 
may increase HPV transmission to their female partners as well as enhance the development of 
penile lesions in comparison to men with low viral load HPV infections.
SUMMARY
Two-year study of 313 uncircumcised Kenyan men found that high versus low penile HPV viral 
load was associated with reduced HPV16 clearance (glans and shaft), and reduced HPV18 
clearance (glans).
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BACKGROUND
Persistent infections with high-risk HPV types 16 and 18 cause approximately 70% of 
cervical cancer in women and one third of penile squamous cell carcinomas in men1–3. HPV 
viral load is an important factor in the natural history of HPV infection; in women, higher 
HPV16 or HPV18 viral loads are associated with decreased HPV clearance and increased 
progression to high grade cervical intraepithelial neoplasia in comparison to lower HPV 
viral loads4–11.
In men, higher penile HPV16 or HPV18 viral loads have been associated with greater HPV 
type concordance with female sexual partners as well as a greater prevalence of flat penile 
lesions in comparison to lower HPV viral loads12–14. It is suggested that higher versus lower 
HPV viral load infections in men increase HPV transmission to their female partners and 
enhance the development of penile lesions by reducing the rate of HPV clearance12,13. 
However, the association between penile HPV viral load and the subsequent rate of HPV 
clearance in men remains unknown. To our knowledge, only one study in Uganda has 
examined the association between penile HPV viral load and HPV persistence; however, this 
study did not examine type-specific HPV viral load and only examined HPV infections in 
the glans anatomical site15.
OBJECTIVE
We present the results of a longitudinal study in uncircumcised men in Kisumu, Kenya, 
examining: (i) the association between HPV16 or HPV18 viral load at baseline and 
participant characteristics; and (ii) the association between penile HPV16 and HPV18 viral 
load and the subsequent rate of HPV clearance in the glans and in the shaft anatomical sites 
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over 24 months. This analysis was restricted to uncircumcised men since male circumcision 
is strongly associated with a higher prevalence of low versus high viral load HPV16 and 
HPV18 infections as well as increased HPV clearance17–19. This analysis focusses on 
further understanding the natural history of HPV infection in uncircumcised men, and 
implications for development of penile lesions in these men as well as HPV transmission to 
their female partners.
STUDY DESIGN
Study population and enrollment
Uncircumcised men in Kisumu, Kenya were invited to participate in a randomized 
controlled trial (RCT) estimating the effect of male circumcision on HIV incidence16. 
Briefly, inclusion criteria were: being uncircumcised, aged 18–24, HIV negative, sexually 
active within the past 12 months and having blood hemoglobin ≥ 90 g/l. The study protocol 
was approved by Institutional Review Boards of the Universities of Illinois at Chicago, 
Manitoba, Nairobi and North Carolina; RTI International and VU University Medical 
Center.
An ancillary HPV study was conducted among men in the RCT who consented to the 
collection of penile exfoliated cells and their shipment overseas for HPV DNA and HPV 
viral load testing. Uncircumcised men who: i) had no HPV follow-up data; ii) were HPV16- 
or HPV18-negative throughout follow-up; iii) had their first HPV16- or HPV18-positive 
result at their last study visit; or iv) had missing HPV viral load data (mainly due to missed 
visits) were excluded from clearance analyses for that specific HPV type (HPV16 or 18) and 
anatomical site (glans or shaft) (Fig.1).
Follow-up and specimen collection
Participant follow-up visits were scheduled at 6-month intervals over 24 months. A 
standardized questionnaire on sociodemographic characteristics and sexual behavior was 
administered by a trained male interviewer at each visit16. Penile exfoliated cell specimens 
were collected by a trained clinical officer at each study visit from two anatomical sites: (i) 
penile shaft and external foreskin (shaft specimen); and (ii) glans, coronal sulcus, and the 
internal tissue of the foreskin (glans specimen)20. Details of the processing and freezing of 
penile swab samples have been described in detail elsewhere13,21. All frozen samples were 
transported to the Department of Pathology at VU Medical Center in Amsterdam, 
Netherlands, for HPV DNA testing.
HPV DNA and Sexually Transmitted Infection (STI) Testing
DNA was isolated from cell samples using NucleoSpin 96 Tissue kit (Macherey-Nagel, 
Germany) and a Microlab Star robotic system (Hamilton, Germany) according to 
manufacturers’ instructions. The presence of human DNA was evaluated by β-globin –
specific PCR, followed by agrose gel electrophoresis22,23. HPV positivity was assessed by 
GP5+/6+PCR, followed by hybridization of PCR products using an enzyme immunoassay 
readout with two HPV oligoprobe cocktail probes that detect 44 HPV types. Subsequent 
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HPV genotyping was performed by Reverse Line Blot (RLB) hybridization of PCR 
products12,22,23.
HIV testing was performed at each visit using two HIV antibody rapid tests (Determine, 
Abbott Diagnostic Division, Hoofddorp, Netherlands; and Unigold, Trinity Biotech, 
Wicklow, Ireland), and confirmed by double enzyme-linked immunosorbent assay (ELISA) 
(Adaltis, Montreal, Canada; Trinity Biotech, Wicklow, Ireland) at the University of 
Nairobi16. A physician or clinical officer conducted a genital exam during which a swab (if 
symptomatic) or urine sample were collected for PCR detection of C. trachomatis and N. 
gonorrhea (Roche Diagnostics). Serum specimens were tested for herpes simplex virus type 
2(HSV-2) ELISA (Kalon).
HPV Viral Load Testing
HPV DNA viral load testing was performed on all cells samples that contained HPV-16 
and/or HPV-18 (regardless of beta-globin results) using a real-time PCR assay and a 
LightCycler instrument (Roche, Mannheim, Germany)24. DNA extraction and purification 
were conducted according to manufacturer instructions using 100 µl of the remaining cell 
suspensions. All samples were run in duplicate in the same run and resulting HPV viral load 
values were averaged. Dilutions of cloned HPV DNA were used to determine the standard 
curve for the HPV target. To calculate the number of copies per sample, the amount of HPV 
DNA in one femtogram was multiplied by the dilution factor and divided by the weight of 
the cloned pHPV viral genome.
HPV viral load was categorized as high (> 250 copies/scape), or low (≤ 250 copies/scrape); 
250 copies/scrape was the limit of quantification of HPV viral load measurements, samples 
with non-quantifiable DNA and quantifiable DNA at or below 250 copies/scrape were 
classified as low viral load. Previous studies using this cut-point for have found that high 
versus low HPV viral load is associated with increased HPV type concordance with female 
partners and a higher prevalence of flat penile lesions12,14.
Statistical Analyses
The distribution of participant characteristics by HPV viral load was examined among all 
HPV16- or HPV18-positive men at baseline; categorical proportions were compared using 
[chi]2 test and continuous variables were assessed using the Wilcoxon rank-sum test. For 
these comparisons, HPV viral load results from the glans and shaft were combined; high 
viral load was defined as >250 copies/scrape in the glans or shaft, and low viral load was 
defined as ≤250 copies/scrape in both the glans and shaft.
All analyses were performed separately for each HPV type (HPV-16 or HPV-18) and 
anatomical site (glans or shaft), since HPV clearance has been shown to vary by anatomical 
site17. For each participant, only the first detected HPV16 or HPV18 infection (prevalent or 
incident) was included. A prevalent infection was defined as an HPV16- or HPV18-positive 
result at baseline, and an incident infection was defined as an HPV16- or HPV18-positive 
result in participants who were negative for that specific HPV type at baseline. Time-to-
clearance since HPV detection was calculated starting at the visit date of first HPV 
detection; for prevalent infections it was baseline, and for incident infections it was the visit 
Senkomago et al. Page 4













date of first HPV detection. Clearance was assumed to occur at the mid-point between the 
last HPV-positive result and the first subsequent HPV-negative result. Men were censored at 
their last observed visit if they remained HPV-positive for the same HPV type at the same 
anatomical site, for each observed consecutive visit. For all clearance analyses, we combined 
incident and prevalent infections for each HPV type at each anatomical site and adjusted for 
HPV infection type (incident versus prevalent) as a covariate. Actual circumcision status at 
each visit was reviewed to verify that men remained uncircumcised during HPV detection 
and clearance. Twelve men assigned to the control arm were circumcised over follow-up, but 
in each case circumcision was performed after HPV clearance so these men were included in 
analyses.
The Kaplan-Meier method was used to estimate HPV clearance of high versus low viral load 
HPV infections over 24 months. Cox regression models were fitted to estimate the adjusted 
hazard ratios (aHRs) for clearance of high versus low viral load HPV infections at 6 months 
after HPV detection. An interaction term between HPV viral load category and time-to-
clearance was included in all the Cox regression models to allow for non-proportional 
hazards in clearance of high and low viral load HPV infections. We examined clearance at 6 
months after HPV detection since this was the first follow-up time point. Potential 
confounders were identified from the literature, and analyzed using a directed acyclic graph. 
All models were adjusted for: educational attainment and bathing frequency at baseline; 
HPV infection type (incident or prevalent infection), HIV infection status and infection with 
multiple HPV types at detection of HPV16/HPV18; and condom use, number of sex 
partners, and infection with other STIs in the previous 6 months25. aHRs could not be 
obtained in cases where all high or low viral load HPV infections had cleared at 6 months 
after detection.
Additional analyses restricted to high viral load infections (with quantifiable viral load 
values >250 copies/scrape) were performed to examine the association between the natural 
log HPV viral load at detection of HPV16 or HPV18 infection, and the rate of HPV 
clearance after 6 months at each site. Sensitivity analyses were conducted restricting 
analyses to beta-globin-positive results.
RESULTS
Of the 2299 uncircumcised men with baseline HPV and viral load results, 1140 men were 
randomized to the control arm, and 1097(96%) had follow-up HPV data (Fig. 1). Over 24 
months, HPV16-positive results were obtained for 238(22%) men for glans samples and 
120(11%) men for shaft samples. A total of 115(10%) men had an HPV 18-positive result 
for glans samples and 54(5%) for shaft samples. HPV16 or HPV18 infections that had 
missing viral load results or that were first detected at the participants’ last study visit were 
excluded from clearance analyses [HPV16 glans=44(18%), HPV16 shaft=23(19%), HPV18 
glans=25(22%) and HPV18 shaft=13(24%)] (Fig.1).
Distribution of Participant characteristics by baseline HPV viral load
Of the 2299 uncircumcised men enrolled in RCT, 239(10%) men were HPV16-positive and 
103(5%) were HPV18-positive in either the glans or shaft (Table 1). Infection with multiple 
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HPV types at baseline was greater in men with high versus low viral load infections for both 
HPV16 (67.9% versus 57.7%, respectively) and HPV18 (80% versus 60.5%, respectively). 
The prevalence of STIs in HPV18-positive men was greater in those with high versus low 
viral load infections (36.9%versus18.4%, respectively), however this association was not 
observed for HPV16 infections. Men with high versus low viral HPV16 or HPV18 viral load 
appeared to have similar distributions of all other variables examined.
Clearance of high versus low viral load HPV16 or HPV18 infections
Over 24 months, a greater proportion of high versus low viral load HPV16 infections were 
observed in the glans than shaft for both HPV16 (56.2% versus 23.7%, respectively) and 
HPV18 (77.8% versus 61.0%, respectively) (Table 2). Whereas the majority of HPV18 
infections (glans and shaft) and HPV16 infections in the glans had high viral loads, a smaller 
proportion of HPV16 infections in the shaft had high viral load (23.7%). Most HPV16 and 
HPV18 infections in the glans or shaft cleared within 6 months of detection (Fig.2). 
Reduced HPV clearance for high versus low viral load infections was observed for HPV16 
infections in the glans [aHR=0.65(0.46-0.92)] and shaft, [aHR=0.44(0.16-0.90)], and for 
HPV18 infections in the glans [aHR=0.05(0.01-0.17)] at 6 months after HPV detection. For 
these three models, p-value for the interaction of HPV viral load category and time to 
clearance were <0.001, 0.014 and <0.001, respectively. The interaction term parameter 
estimates were all negative, indicating that the association between viral load and clearance 
decreased over time. All low viral load HPV18 infections in the shaft had cleared within 6 
months of detection. Sensitivity analyses restricted to beta-globin samples (56.7% in glans 
and 48.4% in shaft) produced similar, but less precise results (Table 2).
HPV Clearance per log HPV viral load among high viral load infections
When analyses were restricted to high viral load infections, a log increase in HPV viral load 
was associated with lower HPV clearance in the glans at 6 months after HPV detection for 
HPV18 [aHR=0.62(0.49-0.78)] but less precise estimates were obtained for HPV16 
[aHR=0.93(0.83-1.05)](Table 3). For both models, p-value for the interaction of log HPV 
viral load and time to clearance was <0.001. aHRs for HPV clearance per log HPV viral 
load at 6 months could not be obtained for HPV16 and HPV18 infections in the shaft due to 
the small number of high viral load infections present at 6 months (HPV16=3; HPV18=2 
infections).
DISCUSSION
Among uncircumcised Kenyan men, reduced HPV clearance, which may also be considered 
as a greater risk of HPV persistence, was observed for high versus low viral load HPV16 and 
HPV18 infections in the glans, and for HPV16 infections in the shaft at 6 months after HPV 
detection. All low viral load HPV18 infections in the shaft had cleared within 6 months of 
detection. Analyses restricted to high viral load infections with quantifiable viral load 
measurements found that a log increase in HPV viral load was associated with decreased 
clearance for HPV18 but less so for HPV16 infections in the glans at 6 months after HPV 
detection.
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To our knowledge, only one study in Ugandan men has examined the association in penile 
HPV viral load and subsequent HPV clearance15. This study found that prevalent high viral 
load infections for high-risk HPV types were more likely to persist to 6 months and 12 
months in comparison to low viral load infections in the glans. These findings are similar to 
our results that showed reduced HPV clearance at 6 months after HPV detection for high 
versus low viral load HPV16 and HPV18 infections in the glans.
We found similar, but attenuated results for the associations between log HPV viral load and 
HPV clearance, in comparison to the respective analyses performed with high versus low 
HPV viral load categories for HPV16 and HPV18 glans infections. This suggests that the 
larger distinction between high versus low HPV viral load (> 250 versus ≤ 250 copies/
scrape) may be more indicative of reduced HPV clearance than smaller changes in log HPV 
viral load.
Reduced HPV clearance of high versus low viral load infections may be explained by the 
greater number of virus-infected cells the immune system has to eliminate26. Alternatively, 
reduced HPV clearance of high versus low viral load infections may reflect a weaker 
immune response to the HPV virus and virus-infected cells 26. Our baseline risk factor 
analyses found that high HPV16 or HPV18 viral load is associated with a higher prevalence 
of multiple HPV types; this suggests that high HPV viral loads are possibly more likely to 
occur in men with weaker immune systems in comparison to low HPV viral loads.
Main strengths of this study include the extensive longitudinal data on HPV viral load 
collected every 6 months for 2 years, and quantitative HPV viral load measurements by real-
time PCR. Our study is also the first to examine the association between type-specific HPV 
viral load and HPV clearance in both the glans and shaft anatomical sites. One limitation is 
that HPV viral load measurements were not normalized to account for number of cells in 
each swab sample (viral load copies/cell). However, the copies/scrape units have been 
previously used to show the associations between high HPV viral load (> 250 copies/scrape) 
and higher prevalence of flat penile lesions as well as increased HPV type concordance with 
female partners12,14. It is also possible that HPV-negative results may reflect HPV viral 
loads below detection level rather than HPV clearance; however this is unlikely since the 
GP5+/6+PCR-RLB procedure has been shown to be highly sensitive and specific for the 
detection of 44 HPV types20. The lower reproducibility of PCR assays when examining low 
viral copy numbers is a possible limitation of this study; however, our examination of 
duplicate samples analyzed in the same run found high agreement of viral load 
measurements, including categorization of low viral load measurements (< 250 copies/
scrape) (Pearson r≥ 0.90). We also observed fairly low beta-globin positivity (56.7% in glans 
and 48.4% in shaft) and it is possible that HPV viral load measurements in this study may be 
underestimated. However, all the clearance analyses restricted to beta-globin-positive 
samples found similar results as the main analyses, and a similar prevalence of beta-globin 
positivity have been observed among men in a similar study in Uganda.18 Other limitations 
of this study include possible length bias in prevalent infections, small number of HPV 
infections, and the inability to know when incident infections occurred or when infections 
cleared.
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In conclusion, this study found that high HPV16 and HPV18 viral load in the glans was 
associated with a reduced rate of HPV clearance in young uncircumcised men. Reduced 
clearance of high viral load penile HPV infections in men may increase HPV transmission to 
their female partners as well as the development of penile lesions in comparison to men with 
low viral load HPV infections.
Acknowledgments
We would like to thank the young men of Kisumu who volunteered to participate in this study. The authors are 
grateful to Chris Wiesen, Chelu Mfalila, Corette Parker and Norma Pugh for their assistance in database 
management, Martin Bogarts for HPV testing and typing, Sonja Gierveld for viral load analysis, and all of the 
UNIM staff, especially the late Dr. Jeckoniah O. Ndinya-Achola for his leadership.
Funding
This research was supported by the National Cancer Institute, National Institutes of Health [grant R01 
CA114773-04 to J.S.S] and the UNC Center for AIDS Research [grant 5 P30 AI050410-13 from the National 
Institute of Allergy and Infectious Diseases, National Institutes of Health]. The main RCT was supported by the 
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health [grant 
AI50440, to R.C. B], the Canadian Institutes of Health Research, and the Chicago Developmental Center for AIDS 
Research (D-CFAR) which is funded by a National Institutes of Health program [P30 AI 082151].
REFERENCES
1. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical 
cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer. 2007; 121(3):621–
632. [PubMed: 17405118] 
2. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus 
prevalence in invasive penile cancer. Cancer Causes & Control. 2009; 20(4):449–457. [PubMed: 
19082746] 
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC monographs on 
the evaluation of carcinogenic risks to humans. Vol. 89. World Health Organization; 2007. 
4. Fontaine J, Hankins C, Money D, et al. Human papillomavirus type 16 (HPV-16) viral load and 
persistence of HPV-16 infection in women infected or at risk for HIV. Journal of Clinical Virology. 
2008; 43(3):307–312. [PubMed: 18786854] 
5. Ramanakumar A, Goncalves O, Richardson H, et al. Human papillomavirus (HPV) types 16, 18, 31, 
45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC 
infectious diseases. 2010; 10(1):326. [PubMed: 21070660] 
6. Xi LF, Hughes JP, Edelstein ZR, et al. Human papillomavirus (HPV) type 16 and type 18 DNA 
loads at baseline and persistence of type-specific infection during a 2-year follow-up. J Infect Dis. 
2009; 200(11):1789–1797. [PubMed: 19848609] 
7. Schlecht NF, Trevisan A, Duarte- Franco E, et al. Viral load as a predictor of the risk of cervical 
intraepithelial neoplasia. International journal of cancer. 2002; 103(4):519–524. [PubMed: 
12478669] 
8. Castle PE, Schiffman M, Scott DR, et al. Semiquantitative human papillomavirus type 16 viral load 
and the prospective risk of cervical precancer and cancer. Cancer Epidemiology Biomarkers & 
Prevention. 2005; 14(5):1311–1314.
9. Gravitt PE, Kovacic MB, Herrero R, et al. High load for most high risk human papillomavirus 
genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the 
development of incident disease. International Journal of Cancer. 2007; 121(12):2787–2793. 
[PubMed: 17722112] 
10. Hesselink AT, Berkhof J, Heideman DA, et al. High- risk human papillomavirus DNA load in a 
population- based cervical screening cohort in relation to the detection of high- grade cervical 
intraepithelial neoplasia and cervical cancer. International Journal of Cancer. 2009; 124(2):381–
386. [PubMed: 19003961] 
Senkomago et al. Page 8













11. Dalstein V, Riethmuller D, Prétet J, et al. Persistence and load of high- risk HPV are predictors for 
development of high- grade cervical lesions: A longitudinal french cohort study. International 
journal of cancer. 2003; 106(3):396–403. [PubMed: 12845680] 
12. Bleeker MC, Hogewoning CJ, Berkhof J, et al. Concordance of specific human papillomavirus 
types in sex partners is more prevalent than would be expected by chance and is associated with 
increased viral loads. Clinical infectious diseases. 2005; 41(5):612–620. [PubMed: 16080082] 
13. Backes DM, Bleeker MC, Meijer CJ, et al. Male circumcision is associated with a lower prevalence 
of human papillomavirus- associated penile lesions among kenyan men. International Journal of 
Cancer. 2011; 130(8):1888–1897. [PubMed: 21618520] 
14. Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. HPV- associated flat penile lesions in men of a 
non- STD hospital population: Less frequent and smaller in size than in male sexual partners of 
women with CIN. International journal of cancer. 2005; 113(1):36–41. [PubMed: 15386360] 
15. Grabowski MK, Gray RH, Serwadda D, et al. High-risk human papillomavirus viral load and 
persistence among heterosexual HIV-negative and HIV-positive men. Sex Transm Infect. 2014 
[Accessed 3/26/2014] 2:57:35 PM doi: 10.1136/sextrans-2013-051230; 10.1136/
sextrans-2013-051230. 
16. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in 
kisumu, kenya: A randomised controlled trial. The Lancet. 2007; 369(9562):643–656.
17. Smith, Jennifer S.; Backes, Danielle M.; Hudgens, Michael G., et al. The effect of male 
circumcision on the incidence and clearance of penile HPV infections in kenyan men; 28th 
International Papillomavirus Conference Proceedings; 2012. p. 167
18. Gray RH, Serwadda D, Kong X, et al. Male circumcision decreases acquisition and increases 
clearance of high-risk human papillomavirus in HIV-negative men: A randomized trial in rakai, 
uganda. J Infect Dis. 2010; 201(10):1455–1462. [PubMed: 20370483] 
19. Senkomago V, Backes DM, Hudgens MG, et al. Acquisition and persistence of human 
papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a 
circumcision trial in kisumu, kenya. J Infect Dis. 2015; 211(5):811–820. [PubMed: 25261492] 
20. Smith JS, Moses S, Hudgens M, et al. Human papillomavirus detection by penile site in young men 
from kenya. Sex Transm Dis. 2007; 34(11):928. [PubMed: 17621251] 
21. Smith JS, Backes DM, Hudgens MG, et al. Prevalence and risk factors of human papillomavirus 
infection by penile site in uncircumcised kenyan men. International journal of cancer. 2010; 
126(2):572–577. [PubMed: 19626601] 
22. Snijders PJ, van den Brule, Adriaan JC, Jacobs MV, Pol RP, Meijer C. HPV DNA detection and 
typing in cervical scrapes. Methods Mol Med. 2005; 119:101. [PubMed: 16350400] 
23. van den, Brule; Adriaan, JC.; Pol, R.; Fransen-Daalmeijer, N.; Schouls, LM.; Meijer, CJ.; Snijders, 
PJ. GP5 /6 PCR followed by reverse line blot analysis enables rapid and high-throughput 
identification of human papillomavirus genotypes. J Clin Microbiol. 2002; 40(3):779–787. 
[PubMed: 11880393] 
24. Hesselink AT, van dB, Groothuismink ZMA, et al. Comparison of three different PCR methods for 
quantifying human papillomavirus type 16 DNA in cervical scrape specimens. J Clin Microbiol. 
2005; 43(9):4868–4871. http://jcm.asm.org/content/43/9/4868.abstract. [PubMed: 16145162] 
25. Textor J, Hardt J, Knüppel S. DAGitty: A graphical tool for analyzing causal diagrams. 
Epidemiology. 2011; 22(5):745. [PubMed: 21811114] 
26. Snijders PJ, van den Brule, Adriaan JC, Meijer CJ. The clinical relevance of human papillomavirus 
testing: Relationship between analytical and clinical sensitivity. J Pathol. 2003; 201(1):1–6. 
[PubMed: 12950011] 
Senkomago et al. Page 9














Study flowchart showing samples included in analyses of HPV viral load and HPV clearance
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Clearance of HPV16 and HPV18 infections by HPV viral load in uncircumcised Kenyan 
men a
aHigh viral load was defined as > 250 copies/scrape, and low viral load was defined as ≤ 250 
copies/scrape at the time of HPV detection.
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Table 1
Baseline participant characteristics, stratified by HPV16 and HPV18 viral load in men in Kisumu, Kenya
HPV16 Prevalent Infections (N =239) a HPV18 Prevalent Infections (N=103) a








Age (years) 20 (19-21;18-24;109) 20 (19-22;18-24;130) 20 (19-22;18-24;65) 20 (20-22;18-24;38)
Education level
  Less than secondary 40 (36.7) 55 (42.3) 23(35.4) 15 (39.5)
  Any secondary or above 69 (63.3) 75 (57.7) 42(64.6) 23 (60.5)
Employment status
  Employed and receiving a salary 6 (5.5) 7(5.4) 7 (10.8) 3 (7.9)
  Self-employed 38 (34.7) 41 (31.5) 21 (32.3) 12 (31.6)
  Unemployed 65 (59.6) 82 (63.1) 37 (56.9) 23 (60.5)
Marital status
  Not married (no live-in partner) 103 (95.4) 125 (96.1) 61 (93.8) 34 (89.5)
  Married (not living with wife) 2 (1.8) 0 4 (6.2) 3 (7.9)
  Married (living with wife) 3 (2.8) 5 (3.9) 0 0
Infection with Multiple HPV types c
  Yes 74 (67.9) 75 (57.7) 52 (80.0) 23 (60.5)
  No 35 (32.1) 55 (42.3) 13 (20.0) 15 (39.5)
Infection with sexually transmitted infections 
d
  Positive 32 (29.3) 45 (34.6) 24 (36.9) 7 (18.4)
  Negative 77 (70.7) 85 (65.4) 41 (63.1) 31 (81.6)
Number of partners in previous 6 months
  0 12 (11.1) 12 (9.3) 8 (12.3) 4 (10.5)
  1 41 (38.0) 63 (48.8) 27 (41.5) 19 (50.0)
  2+ 55 (50.9) 54 (41.9) 30 (46.2) 15 (39.5)
Used condom with intercourse in previous 6 
months
  Always 17 (17.5) 32 (27.1) 11 (18.6) 5 (14.7)
  Inconsistent 54 (55.7) 59 (50.0) 33 (55.9) 18 (52.9)
  Never 25 (25.7) 27 (22.9) 14 (23.7) 11 (32.4)
Bathing Frequency
  Less than daily 3 (2.8) 3 (2.3) 2 (3.1) 2 (5.3)
  Daily 105 (97.2) 127 (97.7) 63 (96.9) 36 (94.7)
a
This table includes only men with detected HPV16 DNA or HPV18 DNA at baseline. High viral load was defined as >250 copies/scrape in the 
glans or shaft; low viral load was defined as ≤ 250 copies/scrape in the both the glans and shaft at the time of HPV detection. Numbers and 
percentages may not sum up to totals due to missing values and rounding.
b
Data are median (IQR; range; n) for continuous data, or n (%) for categorical data.
c
Infection with multiple HPV types was defined as co-infection with at least one other HPV type
d
Positive result for HSV-2, Trichomonas vaginalis, Chlamydia trachomatis or Neisseria gonorrhoeae was examined.
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